Shatarra Salley, APRN
Payments from drug & device makers
Across 94 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$194
- Takeda Pharmaceuticals U.S.A., Inc.$184
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$177
- Axsome Therapeutics, Inc.$165
- AstraZeneca$155
- Ironshore Pharmaceuticals Inc.$151
- plus $765 from 21 others
What the payments were for
- Food & beverage$1,792100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $184 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $177 |
| Axsome Therapeutics, Inc. | 7 | $165 |
| AstraZeneca(2 entities) | 5 | $155 |
| Ironshore Pharmaceuticals Inc. | 7 | $151 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Neurocrine Biosciences, Inc. | 5 | $104 |
| Vanda Pharmaceuticals Inc. | 1 | $70 |
| Johnson & Johnson | 3 | $57 |
| Tris Pharma Inc | 3 | $52 |
| Amgen | 3 | $46 |
| Alkermes, Inc. | 2 | $45 |
| Incyte Corporation | 2 | $38 |
| Corium, LLC | 3 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| Neos Therapeutics, LP | 1 | $19 |
| Merck | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
| Sobi, Inc | 1 | $14 |
| Inari Medical, Inc. | 1 | $13 |
| Exact Sciences | 1 | $13 |
| Novo Nordisk | 1 | $13 |
How this compares
$1,792 in reported general payments places this provider in the 75th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 44 | $532 |
| Bupropion XlBupropion Hcl | 25 | $502 |
| Duloxetine Hcl | 16 | $234 |
| Losartan Potassium | 20 | $196 |
| Quetiapine Fumarate | 20 | $170 |
| Buspirone Hcl | 13 | $157 |
| Omeprazole | 20 | $132 |
| Gabapentin | 11 | $120 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $105 |
| Lisinopril | 17 | $81 |
| Lamotrigine | 14 | $63 |
| Amlodipine Besylate | 25 | $62 |
| Sertraline Hcl | 11 | $54 |
| Alprazolam | 16 | $37 |
| Clonazepam | 14 | $31 |
Paid to pharmacies, not to this prescriber.
Other family in Greer
- Sarah ValerioGreer$76K
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.